<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02386618</url>
  </required_header>
  <id_info>
    <org_study_id>DDC VN 07</org_study_id>
    <nct_id>NCT02386618</nct_id>
  </id_info>
  <brief_title>Endoscopic Treatment for Local Residual Neoplasia</brief_title>
  <official_title>Endoscopic Treatment for Local Residual Neoplasia After Endoscopic Mucosal Resection of the Colorectal Lateral Spreading Tumors (LST)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Vitkovice Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Vitkovice Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Endoscopic mucosal resection (EMR) is considered to be a gold standard of therapy of
      colorectal lateral spreading tumors (LST) without significant risk for lymphatic spread.
      According to the investigators previous study, local residual neoplasia (LRN) after
      conventional endoscopic mucosal resection (EMR)occurs in up to 21% of cases. Endoscopic
      therapy of LRN was not sufficient in 53 % and has not been standardized yet.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2013</start_date>
  <completion_date type="Actual">June 2015</completion_date>
  <primary_completion_date type="Actual">June 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Efficacy of endoscopic treatment od local residual neoplasia (absence of neoplastic tissue in post-EMR scar proven by endoscopic and histologic examination)</measure>
    <time_frame>6 months</time_frame>
    <description>Efficacious endoscopic treatment is defined as absence of neoplastic tissue in post-EMR scar proven by endoscopic and histologic examination in 6 months after endoscopic treatment od local residual neoplasia.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">25</enrollment>
  <condition>Colorectal Cancer</condition>
  <arm_group>
    <arm_group_label>Local residual neoplasia</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Patients with local residual neoplasia in 3 months after endoscopic resection of colorectal lateral spreading tumors diagnosed endoscopically and/or histologically</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Standardized endoscopic treatment of local residual neoplasia</intervention_name>
    <description>Endoscopic treatment will be performed according to the type of local residual neoplasia (LRN): A - endoscopically negative scar and neoplastic tissue found only in biopsy specimens - treatment by argon plasmacoagulation, B - endoscopically aparent LRN &lt; 5 mm - forceps biopsy + argon plasmacoagulation, C - endoscopically evident LRN &gt; 5 mm + lifting during submucosal injection - endoscopic mucosal resectio + argon plasmacoagulation, D - endoscopically evident LRN &gt; 5 mm + non-lifting during submucosal injection - endoscopic submucosal disection (ESD) or surgical resection</description>
    <arm_group_label>Local residual neoplasia</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients older than 18 years

          -  patients with local residual neoplasia in scar in three months after endoscopic
             mucosal resection for laterally spreading tumor (0-IIa &gt; 10 mm)

          -  signed informed consent

        Exclusion Criteria:

          -  incomplete endoscopic mucosal resection

          -  previous therapy for local residual neoplasia

          -  difficult or impossible localization of post-EMR scar
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Premysl Falt, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Vitkovice Hospital, Ostrava</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Vitkovice Hospital</name>
      <address>
        <city>Ostrava</city>
        <zip>703 84</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Czech Republic</country>
  </location_countries>
  <verification_date>October 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 19, 2013</study_first_submitted>
  <study_first_submitted_qc>March 11, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 12, 2015</study_first_posted>
  <last_update_submitted>October 4, 2015</last_update_submitted>
  <last_update_submitted_qc>October 4, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 6, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Vitkovice Hospital</investigator_affiliation>
    <investigator_full_name>Premysl Falt, M.D., Ph.D.</investigator_full_name>
    <investigator_title>MUDr. Premysl Falt</investigator_title>
  </responsible_party>
  <keyword>colorectal cancer</keyword>
  <keyword>laterally spreading tumors</keyword>
  <keyword>endoscopic mucosal resestion</keyword>
  <keyword>local residual neoplasia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colorectal Neoplasms</mesh_term>
    <mesh_term>Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

